Albert Einstein Medical Center is conducting a study to measure the impact that education, health screenings and genetic counseling have on menopausal women and their decisions about hormone replacement therapy (HRT).
As part of the study, Einstein is offering a free program–the Comprehensive Risk Assessment Program for Menopausal Women–to help women and their doctors weigh personal health benefits against the risks of taking HRT.
HRT, believed to be protective against heart disease, America's number one killer, and osteoporosis, the bone-thinning disease, has become controversial in recent years because of its association with breast cancer.

Lisa Jablon, MD, Director, High Risk Breast Program

According to breast surgeon Lisa Jablon, MD, Director of Einstein's High Risk Breast Program, there may be a slight increased risk of breast cancer in women who take HRT for more than five or 10 years. But, for most women, the benefits clearly seem to outweigh the risks.

Study participants receive free genetics, menopause and nutrition counseling as well as free screenings for osteoporosis, heart disease and breast cancer. To participate, women must be nearing, experiencing or passed menopause and have a family history of breast cancer.

The program is funded by a grant from the Albert Einstein Society.

To find out if you are eligible to become a participant, call (215) 456-7215.


Back to Breast Cancer Studies